Agios Pharmaceuticals, Inc. (AGIO)
NASDAQ: AGIO · Real-Time Price · USD
27.73
+0.31 (1.13%)
At close: Dec 5, 2025, 4:00 PM EST
28.00
+0.27 (0.97%)
After-hours: Dec 5, 2025, 7:59 PM EST
Agios Pharmaceuticals Analyst Ratings
Total Analysts
9
Consensus Rating
Buy
Price Target
$32.13
Upside
+15.87%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Citigroup | Citigroup | Strong Buy Initiates $38 | Strong Buy | Initiates | $38 | +37.04% | Nov 26, 2025 |
| Truist Securities | Truist Securities | Strong Buy Initiates $32 | Strong Buy | Initiates | $32 | +15.40% | Nov 24, 2025 |
| JP Morgan | JP Morgan | Hold Maintains $37 → $20 | Hold | Maintains | $37 → $20 | -27.88% | Nov 21, 2025 |
| RBC Capital | RBC Capital | Buy → Hold Downgrades $57 → $28 | Buy → Hold | Downgrades | $57 → $28 | +0.97% | Nov 20, 2025 |
| B of A Securities | B of A Securities | Strong Buy Maintains $54 → $32 | Strong Buy | Maintains | $54 → $32 | +15.40% | Nov 20, 2025 |
| Leerink Partners | Leerink Partners | Hold → Buy Upgrades $40 → $34 | Hold → Buy | Upgrades | $40 → $34 | +22.61% | Nov 20, 2025 |
| Goldman Sachs | Goldman Sachs | Hold Maintains $40 → $25 | Hold | Maintains | $40 → $25 | -9.84% | Nov 20, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $56 → $48 | Strong Buy | Maintains | $56 → $48 | +73.10% | Nov 20, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $56 | Strong Buy | Reiterates | $56 | +101.95% | Sep 4, 2025 |
| Scotiabank | Scotiabank | Buy Maintains $71 → $65 | Buy | Maintains | $71 → $65 | +134.40% | Jul 28, 2025 |
| B of A Securities | B of A Securities | Strong Buy Maintains $52 → $51 | Strong Buy | Maintains | $52 → $51 | +83.92% | Jul 22, 2025 |
| Scotiabank | Scotiabank | Buy Maintains $74 → $71 | Buy | Maintains | $74 → $71 | +156.04% | May 2, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $58 | Strong Buy | Reiterates | $58 | +109.16% | Feb 24, 2025 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates n/a | Buy | Reiterates | n/a | n/a | Dec 18, 2024 |
| RBC Capital | RBC Capital | Buy Maintains $55 → $57 | Buy | Maintains | $55 → $57 | +105.55% | Dec 10, 2024 |
| Scotiabank | Scotiabank | Buy Maintains $53 → $75 | Buy | Maintains | $53 → $75 | +170.47% | Dec 9, 2024 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.